- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
More than one in ten patients affected by anxiety and depression following ICD implantation
Australia: A recent study published in EP Europace has reported a high prevalence of depression and anxiety in ICD (implantable cardioverter defibrillators) patients, especially in those who experience shocks.
"The prevalence of PTSD (post-traumatic stress disorder) following ICD implantation is of particular concern," the researchers wrote in their study.
The study revealed that nearly one-third of patients with an implanted device to prevent sudden death have anxiety in the first year, while depression affects one in five.
“Implantable cardioverter defibrillators (ICDs) are effective at extending patients’ lives, but we need to make sure that’s a good quality life,” said study author Professor Hannah Keage of the University of South Australia, Adelaide, Australia. “Rates of mood disorders in people with an ICD are much higher than in the general population, suggesting that psychological assessment and therapy should be integrated into the routine care of these patients.”
An ICD is recommended for people at high risk of a life-threatening heart rhythm and those with cardiac arrest.2 Anxiety and depression are associated with a higher likelihood of premature death in patients with an ICD.3 This study compiled the best available evidence to determine levels of depression, anxiety and post-traumatic stress disorder (PTSD) in patients with an ICD. Professor Keage explained: “I am a professor of psychology and have been working with cardiologists for many years. They noticed that mood disorders were common in their ICD patients so we teamed up to get an idea of how widespread this was.”
The analysis included 109 studies covering 39,954 ICD patients. When the prevalence of anxiety, depression and PTSD was examined from the time of ICD insertion to more than one year of follow-up, rates were 23%, 15% and 12%, respectively. Rates of these conditions in the general population are estimated at 13%, 7% and 1-2%, respectively. Further detail was available for anxiety and depression, which showed higher rates in the initial stages after implantation. In the first five months, 32% and 23% had anxiety and depression, respectively. Six to 12 months after insertion, rates of anxiety and depression had declined to 29% and 21%, respectively. Further declines were observed beyond 12 months after implantation, when rates were 22% and 15%, respectively.
When an ICD detects a dangerously fast heart rhythm, it delivers a shock to return it to normal, which can feel like being kicked in the chest. The analysis found that patients who had shocks were four times more likely to have anxiety and nearly twice as likely to have depression compared to those without shocks. In an analysis by sex, women were more likely than men to have anxiety after receiving their ICD.
Professor Keage said: “Rates of all three mood disorders were notably high compared to what we would expect in people without an ICD, particularly for PTSD. Around 30% of ICD patients will experience a shock in the first two years and for some patients this is a constant fear that affects decisions about driving, swimming, and so on. The decline in mood disorders over time could be due to a number of factors including patients getting psychological help or adapting to their new life. We can’t discount the possibility that healthier people tend to stay in studies longer while ill-health people are more likely to drop out. The sex differences were expected as rates of anxiety are generally higher in women than men.”
The analysis also examined mood disorders in non-ICD participants of the 109 studies. An estimated 23% of ICD patients’ partners had anxiety following the implantation and 14% had depression-which was similar to the patients' rates. Patients with cardiac disease but no ICD also had similar rates of mood disorders as those with an ICD.
Professor Keage said: “Partners are clearly worried about their loved one undergoing surgery and then potentially having a shock. Involving ICD patient partners in psychological therapies improves patients’ physical and psychological health more than attending alone.4 The findings in cardiac patients make a lot of sense, as heart health and mood disorders go hand in hand. Psychological ill-health can also lead to heart problems through chronic stress and unhealthy lifestyles. Psychologists have had little involvement in the care of cardiac patients but this needs to change. I would encourage patients and partners to seek help if their mood is low or they are overly worried, as there are evidence-based therapies for anxiety, depression and PTSD.”
Reference:
Erica S Ghezzi and others, Burden of mood symptoms and disorders in implantable cardioverter defibrillator patients: a systematic review and meta-analysis of 39 954 patients, EP Europace, Volume 25, Issue 6, June 2023, euad130, https://doi.org/10.1093/europace/euad130.
Dr Kamal Kant Kohli-MBBS, DTCD- a chest specialist with more than 30 years of practice and a flair for writing clinical articles, Dr Kamal Kant Kohli joined Medical Dialogues as a Chief Editor of Medical News. Besides writing articles, as an editor, he proofreads and verifies all the medical content published on Medical Dialogues including those coming from journals, studies,medical conferences,guidelines etc. Email: drkohli@medicaldialogues.in. Contact no. 011-43720751